Zdrowie i gospodarka · 17/09/2009
FDA Announces Availability of Guidance for Industry: Considerations for Allogeneic Pancreatic Islet Cell Products
The FDA has released a guidance document providing recommendations for manufacturers and investigators involved in clinical trials for allogeneic pancreatic islet cell products to treat type 1 diabetes, finalizing a draft from 2008.